Navigation Links
Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products
Date:6/8/2011

EAST BRUNSWICK, N.J. and EDISON, N.J., June 8, 2011 /PRNewswire/ -- Amerigen Pharmaceuticals Limited and AustarPharma, LLC today announced they had entered into a broad-based collaboration agreement regarding the development of generic oral controlled release products. Under the terms of the agreement, AustarPharma will use its proprietary technologies to develop and manufacture products for Amerigen to commercialize in the United States and other territories. AustarPharma received an up-front fee and is eligible for additional product specific development milestones, plus manufacturing revenues and royalties on any commercialized products.

"This collaboration allows Amerigen to augment its internal product development activities and accelerate the company's efforts to build a portfolio of differentiated, high value generic pharmaceuticals," said Jonathan Embleton, Chief Business Officer for Amerigen. "We look forward to working with AustarPharma to complete the development and file for approval for some technically very challenging products."

President & CEO of AustarPharma, Dr Ron Liu commented, "As a technology based company, AustarPharma focuses on developing high technology barrier products. The combination of Amerigen's development, regulatory and commercial capabilities and AustarPharma's advanced controlled-release technologies in generic drug development will greatly benefit both companies. We highly value this collaboration."

About Amerigen

Amerigen Pharmaceuticals is a group of companies engaged in all phases of the generic pharmaceutical business, with operations in the US and China. The group is controlled by Amerigen Pharmaceuticals Limited. The US regulatory and commercial activities within the group are conducted by Amerigen Pharmaceuticals Inc., based in East Brunswick, NJ, USA. The group's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Limited, is located in Suzhou, Jiangsu Province. The group has an a
'/>"/>

SOURCE Amerigen Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BOSTON , September 16, 2014 ... Fiona Marshall , will give a presentation entitled " ... StaR ®   technology " ... and Development " virtual symposium run by Chemical & Engineering ... symposium is on Wednesday, 24 September 2014; Dr Marshall,s presentation ...
(Date:9/15/2014)... FRANCISCO , Sept. 15, 2014 ... studies presented at the American Society for Radiation ... its Decipher® Prostate Cancer Classifier, a genomic test ... influence treatment decisions and improve patient outcomes for ... These presentations follow a recently published study that ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... to 2020″, provides key market data on the ... report provides value, in millions of US dollars, ... dollars) within market segments Invasive Body Contouring Devices ... Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) ...
Breaking Medicine Technology:Heptares to Present on Structure-Based Drug Design Using G Protein-Coupled Receptors at Inaugural Chemistry & Engineering News Virtual Symposium 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5
... 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... emerging leader in the development, assembly, marketing and sale ... today announced that it was granted three new patents ... of China ("SIPO"). The patent awards were related to ...
... Cellular Dynamics International (CDI) today announced the online publication ... demonstrating for the first time a methodology for researchers ... blood samples through the creation of induced pluripotent stem ... B-cell lines reprogrammed to EBV-free induced pluripotent stem cells," ...
Cached Medicine Technology:Dehaier Strengthens Intellectual Property Portfolio 2Dehaier Strengthens Intellectual Property Portfolio 3Cellular Dynamics International Unlocks the Potential of Banked Blood Samples 2
(Date:9/16/2014)... Discussion abstracts to be presented at the ESMO 2014 ... 2014 at 12:00 (CEST) to give you a first ... medical oncology Congress, under the leading theme Precision Medicine ... where genuinely targeted therapy is now possible for an ... are all working towards a common goal --improved patient ...
(Date:9/16/2014)... Perkins, OK (PRWEB) September 16, 2014 ... Superfood, rich in iron and potassium. They are ... high nutritional values and their healing and health ... and meaty texture Shiitakes can stimulate and strengthen ... infections. Shiitakes contain polycharrides, including beta ...
(Date:9/16/2014)... Atlanta, GA (PRWEB) September 16, 2014 ... cloud-based clinical, business management and billing software solutions ... immediate availability of its latest release of ... providers, orthotics and prosthetics providers as well as ... for prior authorization requests (PARs), electronic purchasing, document ...
(Date:9/16/2014)... Albany, New York (PRWEB) September 16, 2014 ... intelligence firm states that the global facial care market ... billion by 2019. The report, titled ‘Facial Care Market ... Facial Creams, Face Wash, Cleansing Wipes, Serums and Masks ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 ...
(Date:9/16/2014)... Cloud based mobile app builder Appy ... API’S to serve m3u8 streams on Android & iOS. ... video events with hundreds of thousands of simultaneous viewers ... is known for making beautiful and interactive apps for ... 8 and already over 100,000 apps have passed through ...
Breaking Medicine News(10 mins):Health News:ESMO 2014 Congress Preview 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 3Health News:Brightree Announces Availability of Latest Release 2Health News:Brightree Announces Availability of Latest Release 3Health News:Brightree Announces Availability of Latest Release 4Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 2Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 3
... their seatbelts than the rest of the population, adding ... growing problem. , The connection was made by ... Meharry Medical College in Nashville, Tenn. , We found ... Schlundt, associate professor of psychology and assistant professor of ...
... as a non-invasive way to determine the existence and ... development of pharmacologic strategies to combat the condition. These ... journal published by John Wiley & Sons on behalf ... Diseases (AASLD). The article is also available online at ...
... two editorials published in the September 2007 issue ... medical ethicist discussed whether doctors should participate in ... discussions about physician involvement in capital punishment have ... court systems. And the North Carolina Medical Board ...
... Commissioner Dr. Thomas R. Frieden, and Consumer Affairs Commissioner Jonathan ... City Youth Risk Behavior Survey (YRBS) showing that cigarette smoking ... 2005 and 2007. The citys teen smoking rate has dropped ... 17.6 percent in 2001 to 8.5 percent in 2007. The ...
... BOSTON, Mass. (Jan. 2, 2008) Athanasios Zavras began ... reports linked oral osteoporosis meds to bone death in ... women and men taking these drugs to postpone dental ... exacerbate the problem. Thats when Zavras, an associate professor ...
... misguided zealots are promoting numerous stress reduction devices, ... The vast majority are supported only by ... others. Very often, as in the case ... stress, scholarly articles from prestigious journals are cited ...
Cached Medicine News:Health News:Obesity linked to decreased seatbelt use 2Health News:MRI techniques evolving towards better assessment of liver fibrosis 2Health News:Mayo Clinic Proceedings provides forum for debate about capital punishment 2Health News:Mayo Clinic Proceedings provides forum for debate about capital punishment 3Health News:Smoking rate among New York City teens was lowest on record in 2007 2Health News:Smoking rate among New York City teens was lowest on record in 2007 3Health News:Oral osteoporosis meds appear to reduce the risk of jaw degradation 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: